ATG7 inhibitors and the uses thereof
US10865208B2 · kind B2 · utility
0Cited by
1References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2017 |
| Grant date | Dec 15, 2020 |
| Priority date | — |
| Expiry date | Nov 10, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D333/54
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are chemical entities which are compounds of formula (I): or a pharmaceutically acceptable salt thereof, wherein R1, R2, and Ra have the values described herein. Chemical entities according to the disclosure can be useful as inhibitors of ATG7. Further provided are pharmaceutical compositions comprising a chemical entity of the disclosure and methods of using the compositions in the treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.